We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

133 hedge funds and large institutions have $477M invested in Provention Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 17 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

329% more call options, than puts

Call options by funds: $19.4M | Put options by funds: $4.53M

235% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 17

155% more capital invested

Capital invested by funds: $187M → $477M (+$290M)

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

19% more funds holding

Funds holding: 112 → 133 (+21)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
133
Holders Change
+21
Holders Change %
+18.75%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
38
Increased
57
Reduced
17
Closed
17
Calls
$19.4M
Puts
$4.53M
Net Calls
+$14.9M
Net Calls Change
+$11.7M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.38M
2
6CM
683 Capital Management
New York
+$4.44M
3
BlackRock
BlackRock
New York
+$4.43M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.35M
5
Invesco
Invesco
Georgia
+$4.1M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$26.2M
2
DCM
DG Capital Management
New York
-$2.25M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.54M
4
CS
Candriam SCA
Luxembourg
-$889K
5
Osaic Holdings
Osaic Holdings
Arizona
-$691K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
126
US Bancorp
Minnesota
$1.76K +$1.35K +167 New
MA
127
Montag & Associates
Georgia
$1.06K +$807 +100 New
Nisa Investment Advisors
128
Nisa Investment Advisors
Missouri
$1K +$516 +64 New
SWM
129
Spire Wealth Management
Virginia
$1K +$807 +100 New
Dimensional Fund Advisors
130
Dimensional Fund Advisors
Texas
$804 -$3.81K -472 -0.6%
S
131
SignatureFD
Georgia
$708 +$541 +67 New
SPIA
132
Steward Partners Investment Advisory
New York
$676 -$3.12K -386 -86%
TF
133
TimeScale Financial
Massachusetts
$450 – – –
DCM
134
DG Capital Management
New York
– -$2.25M -499,271 Closed
PA
135
Perceptive Advisors
New York
– -$498K -110,728 Closed
XT
136
XTX Topco
Cayman Islands
– -$390K -86,763 Closed
Marshall Wace
137
Marshall Wace
United Kingdom
– -$362K -80,685 Closed
GCM
138
Graham Capital Management
Connecticut
– -$360K -80,163 Closed
GCP
139
GSA Capital Partners
United Kingdom
– -$276K -61,337 Closed
PP
140
PDT Partners
New York
– -$232K -51,594 Closed
Renaissance Technologies
141
Renaissance Technologies
New York
– -$141K -31,321 Closed
SO
142
STRS Ohio
Ohio
– -$130K -28,900 Closed
Ensign Peak Advisors
143
Ensign Peak Advisors
Utah
– -$112K -24,840 Closed
ACM
144
Aquatic Capital Management
Illinois
– -$86K -19,200 Closed
SFI
145
Susquehanna Fundamental Investments
Pennsylvania
– -$84K -18,591 Closed
FA
146
Forefront Analytics
Pennsylvania
– -$68K -14,997 Closed
JWCA
147
J.W. Cole Advisors
Florida
– -$66K -14,750 Closed
AQR Capital Management
148
AQR Capital Management
Connecticut
– -$62K -13,864 Closed
Wolverine Trading
149
Wolverine Trading
Illinois
– -$58K -13,114 Closed
CF
150
Cantor Fitzgerald
New York
– -$45K -10,000 Closed
2 3 4 5
6

PRVB Hedge Fund Activity: Q4 2022 in Review

133 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q4 2022, worth a combined $477M — up 155% from $187M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PRVB positions and 17 closed out — a net gain of 21 holders — while 57 added to existing stakes and 17 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $8.38M. The largest seller was Adage Capital Partners, cutting an estimated $26.2M.

  • 133 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q4 2022, up from 112 in Q3 2022.
  • Funds reported $477M of Provention Bio, Inc. Common Stock stock for Q4 2022, up 155% quarter-over-quarter.
  • 38 funds opened new Provention Bio, Inc. Common Stock positions in Q4 2022 and 17 closed out, a net change of +21 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q4 2022 was D.E. Shaw & Co, an estimated $8.38M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q4 2022 was Adage Capital Partners, an estimated $26.2M sold.

Based on aggregated 13F filings for Q4 2022.